Why the study?
Radiation is associated with tissue damage and increased risk of atherosclerosis, but treatments are lacking and mechanistic understanding of its impact on tissue repair is very limited.
Does Resolvin D1 treatment improve efferocytosis and reduce plaque necrosis in sublethally irradiated mice?
Does Resolvin D1 treatment improve efferocytosis and reduce plaque necrosis in sublethally irradiated mice?
Resolvin D1 mitigates radiation-induced macrophage senescence and atherosclerosis by restoring efferocytosis and reducing plaque necrosis in preclinical models.
May support RvD1 for radiation-associated atherosclerosis; hypothesis-generating and requires clinical trials.
Radiation is associated with tissue damage and increased risk of atherosclerosis, but there are currently no treatments and a very limited mechanistic understanding of how radiation impacts tissue repair mechanisms. We uncovered that radiation significantly delayed temporal resolution programs that were associated with decreased efferocytosis in vivo. Resolvin D1 (RvD1), a known proresolving ligand, promoted swift resolution and restored efferocytosis in sublethally irradiated mice. Irradiated macrophages exhibited several features of senescence, including increased expression of p16INK4A and p21, heightened levels of SA-β-gal, COX-2, several proinflammatory cytokines/chemokines, and oxidative stress (OS) in vitro, and when transferred to mice, they exacerbated inflammation in vivo. Mechanistically, heightened OS in senescent macrophages led to impairment in their ability to carry out efficient efferocytosis, and treatment with RvD1 reduced OS and improved efferocytosis. Sublethally irradiated Ldlr−/− mice exhibited increased plaque necrosis, p16INK4A cells, and decreased lesional collagen compared with nonirradiated controls, and treatment with RvD1 significantly reduced necrosis and increased lesional collagen. Removal of p16INK4A hematopoietic cells during advanced atherosclerosis with p16-3MR mice reduced plaque necrosis and increased production of key intraplaque-resolving mediators. Our results demonstrate that sublethal radiation drives macrophage senescence and efferocytosis defects and suggest that RvD1 may be a new therapeutic strategy to limit radiation-induced tissue damage.
No takes yet. Share an insight, caveat, or question.
Sadhu et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: